SUMMARY Pancreatic and salivary amylase/creatinine clearance ratios in patients with various degrees of renal impairment were compared with those obtained for control subjects. In chronic renal insufficiency (mean GFR 30 ml/min ± 15 SD; n = 13) the clearance ratios for pancreatic (mean 3X5 + 1X85 SD) and salivary (mean 2.3 + 1-3 SD) amylase were significantly higher (p < 0 05) than those in controls. Corresponding control values (n = 26) were 2-64 + 0-86 (pancreatic) and 1 64 + 0 95 (salivary). Three patients showed values above the normal limit. In the diabetic group (mean GFR 41 ml/min + 22 SD; n = 10) salivary amylase/creatinine clearance ratios (mean 2-36 + 1-55 SD) were significantly higher than in controls (p < 0 05). Three patients showed raised values. Pancreatic amylase clearance was raised in only one of these patients. Three patients with terminal disease (mean GFR 1Oml/min) showed markedly raised (two-to threefold) clearance ratios for both salivary and pancreatic amylase. Of a total of 26 patients, eight had increased total amylase/creatinine clearance ratios. Pancreatic amylase/creatinine clearance was increased in seven patients, while nine patients showed raised salivary amylase/creatinine ratios. Patients with raised clearance ratios did not have clinical evidence of pancreatitis. We suggest that, in the presence of impaired renal function, a high amylase/creatinine clearance ratio need not be indicative of pancreatic disease.
The amylase (am)/creatinine (cr) clearance (C) ratio (Cam/Ccr) has been suggested as a useful aid in diagnosing acute pancreatitis in patients with renal insufficiency (Levitt et al., 1969) . Some authors have reported that the ratio Cam/Ccr remains normal in renal insufficiency (Blainey and Northam, 1967; Levitt et al., 1969) and is increased in the presence of pancreatitis (Mulhausen et al., 1969; Drieling et al. 1974; Warshaw and Fuller, 1975) . In contrast, recent, studies (Morton et al., 1976; Lankisch et al., 1977) have found raised Cam/Ccr ratios in patients with chronic renal failure without accompanying pancreatitis. These studies measured the clearance of total (T) amylase. In investigating this problem we studied the clearance of both pancreatic (P) and salivary (S)-type amylase in 15 patients with chronic renal insufficiency (CRI) and 11 with diabetes mellitus (DM), all with impaired renal function. ' Present address: Meath Hospital, Dublin 8.
Received for publication 31 Table 3 . Two of these had term- inal renal failure one of whom was a diabetic; the third patient had terminal heart failure.
All patients in Tables 1 and 2 were clinically stable and had no clinical evidence of pancreatitis. The diabetic population were all controlled with monocomponent insulins; one had ketoacidosis.
Control subjects (n = 26) comprised 12 males and (O'Donnell et al., 1977) . Albumin (7 4 ,uM) was incorporated in the reaction mixture in the case of all urine analyses. Creatinine estimations were carried out using the creatinine Rapid Stat Kit (Pierce, Rockford, Illinois 
Results
Differential serum amylase values for the 13 patients with chronic renal insufficiency are shown in Table 1 together with the amylase/creatinine clearance values for total, salivary, and pancreatic amylase. The glomerular filtration rates (GFR) as measured by creatinine clearance are also given. These range from 7-8 ml/min to 56 ml/min (mean 30 ml/min ± 15 SD). Six patients had total serum amylase values above our upper limit. Five of these patients had raised serum pancreatic amylase values with normal salivary levels. The sixth patient showed a raised serum salivary amylase. When this group of 13 patients was compared with 69 control subjects the serum salivary and pancreatic amylase levels were both significantly higher in the patients with chronic renal insufficiency ( Table 4 ). Three of the 13 patients in Table 1 had abnormal total amylase/creatinine clearance ratios-that is, > 38 %. Salivary amylase clearance was increased-that is, > 3 5 %d-in two and pancreatic amylase clearance was increased -that is, > 4-4%-in all three patients. Taken as a group, the mean total amylase/creatinine clearance ratio was significantly higher in these 13 patients when compared with controls (p < 0-025) ( Table 5 ). This was due to an increased clearance of both salivary and pancreatic components.
Data related to the diabetic population are shown in Table 2 . The GFR ranged from 15 to 81 ml/min (mean 41 ml/min ± 22 SD). Hyperamylasaemia was present in two of the 10 patients; in one case (M. D.) this was due to pancreatic amylase only, while in the other (P. F.) both pancreatic and salivary amylase levels were elevated. When compared with the control group serum salivary levels were significantly higher (P <0-01) in the diabetic patients (Table 4) . Table 3 . While only one patient showed hyperamylasaemia all three patients had markedly increased clearance of both salivary and pancreatic amylase.
The significantly increased rate of pancreatic amylase clearance relative to salivary amylase clearance (p < 0.0005) in control subjects has already been reported (Hegarty et al., 1978) . This degree of preferential clearance of pancreatic relative to salivary amylase is markedly reduced in patients with renal insufficiency (Tables 3 and 6) .
Discussion
This present study has demonstrated that, of 15 patients with chronic renal insufficiency, 10 showed normal clearance ratios for both salivary and pancreatic amylase. Of the remaining five patients, two had terminal disease and two had nephrotic syndrome, all with increased salivary and pancreatic amylase/creatinine clearance ratios. The fifth patient had hypernephroma and showed a high clearance ratio for pancreatic amylase only. It would appear that in terminal disease associated with renal failure a high amylase/creatinine clearance ratio need not indicate pancreatic disease. Post-mortem studies in two terminal patients failed to show evidence of pancreatitis. The two patients with nephrotic syndrome are of definite interest, as their high clearance values may well be related to the heavy proteinuria present. The reason for the high pancreatic amylase clearance ratio in the hypernephroma patient is unclear; the capacity of certain tumours to produce amylase has been described (Ammann et al., 1973; Berk and Fridhandler, 1975) .
Eight of the 11 diabetic patients showed normal clearance values. Of the remaining three, one had terminal renal failure (GFR 5 ml/min) with increased clearance ratio of both salivary and pancreatic amylase. One patient was mildly ketoacidotic and showed a raised clearance ratio for salivary amylase only. The explanation for the increased salivary amylase clearance ratio in the third patient is not clear.
The precise mechanisms of amylase transfer within the kidney have not yet been clarified. It was earlier concluded that amylase clearance was essentially a function of glomerular filtration without significant tubular reabsorption (McGeachin and Hargan, 1956; 1957; Duane et al., 1971) . Recent work by Johnson et al. (1976) provides strong evidence in favour of tubular reabsorption of amylase in man. This has also been shown experimentally in the rat (Noda, 1972; Fredriksson and Jacobson, 1974) . The more rapid clearance of pancreatic amylase relative to salivary amylase (Duane et al., 1972; Takeuchi et al., 1974; Fridhandler et al., 1972; Long and Grider, 1976; Hegarty et al., 1978) may be related to a more active reabsorption of salivary amylase by the proximal or distal tubule. Loss of this preferential clearance of pancreatic amylase relative to salivary amylase is evident in renal insufficiency (Tables 3 and  6 ) and is undoubtedly related to the accompanying renal tubular atrophy. Loss of tubular function would also explain why both salivary and pancreatic amylase/creatinine clearance ratios are sometimes raised in renal disease. Acute pancreatitis, which is accompanied by renal tubular dysfunction, also leads to increased clearance ratios for both salivary and pancreatic amylase (Johnson et al., 1976) . Interestingly, in chronic pancreatitis, where tubular function is not impaired, as evidenced by normal clearance of fl2-microglobulin, Cp/Cer only is raised (Hegarty et al., 1978) . Our study demonstrates a rise of both salivary and pancreatic amylase in the serum of patients with chronic renal insufficiency compared with controls. This increase (-two fold) is less than the corresponding rise in serum creatinine (-three fold) (Table 4) . Since the quotient urinary amylase/ urinary creatinine is not significantly higher in patients with chronic renal insufficiency relative to controls (Table 5) , the increased Cam/Ccr ratio must also be related to the greater rise in serum creatinine than in serum amylase (see clearance equation).
This finding of an increased amylase/creatinine clearance ratio in some patients with chronic renal insufficiency agrees with the results of Morton et al. (1976) and Lankisch et al. (1977) . A high amylase/ creatinine clearance ratio has also been reported in severe renal failure (GFR less than 25 ml/min) by Pedersen et al. (1976) . The severity of renal insufficiency may explain why the results differ from those previously reported (Blainey and Northam, 1967; Levitt et al., 1969) .
The majority of our patients with chronic renal insufficiency had normal amylase/creatinine clearance ratios. Warshaw (1976) has suggested that perhaps the most assured use of the amylase/creatinine clearance ratio will be when it is not raised, thereby excluding pancreatitis. The validity of this suggestion appears doubtful in view of the recent report (Duirr et al., 1977 ) that some patients with acute pancreatitis have normal Cam/Cer ratios.
Our results show that the increased amylase/ creatinine clearance ratio in chronic renal insufficiency could be due to both salivary and pancreatic amylase. The clearance ratio should therefore be interpreted with caution in the presence of severe renal insufficiency. A high ratio need not be indicative of pancreatitis, since our patients had no clinical evidence of exocrine pancreatic disease and were not on drugs which could cause hyperamylasaemia. 
